Last reviewed · How we verify
NCT07145489
Infrared Photobiomodulation in Humans With Epilepsy
NA trial testing photobiomodulation in Drug Resistant Epilepsy in 13 participants. Currently enrolling.
25 September 2026
Quick facts
| Lead sponsor | Beth Israel Deaconess Medical Center |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 13 |
| Start date | 25 November 2025 |
| Primary completion | 25 September 2026 |
| Estimated completion | 25 September 2027 |
| Sites | 1 location across United States |
Drugs / interventions tested
- photobiomodulation
Conditions studied
- Drug Resistant Epilepsy — all drugs for Drug Resistant Epilepsy →
Sponsor
Beth Israel Deaconess Medical Center
Who can join
18 and older, any sex, with Drug Resistant Epilepsy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Drug-resistant epilepsy represents roughly 40% of people with epilepsy. It is very challenging to stop seizures in this condition, and the treatment options are limited. This study aims to investigate a new treatment that involves using infra-red light. In animals, this treatment has shown promise as a possible way to reduce seizures, but it has not been tested in humans for this. The investigators are interested to know if it can reduce seizures, and how comfortable it is to be treated with this therapy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07145489
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of photobiomodulation
Trials testing the same drug.
- NCT07307885 — The Effect of Photobiomodulation on Pressure Ulcers · NA · not yet recruiting
- NCT07579585 — Effects of Photobiomodulation in Hemophilia Patients. · NA · recruiting
- NCT06640439 — LED Therapy for Third Molar Surgery · EARLY_PHASE1 · not yet recruiting
- NCT07062302 — Effectiveness of Low-Level Light Therapy for Vocal Fatigue · NA · completed
- NCT05413993 — Effect of Photobiomodulation on ph and Salivary Flow · NA · completed
Other recruiting trials for Drug Resistant Epilepsy
Currently open trials in the same condition.
- NCT06899230 — Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of iQ-007 · Phase 1 · active not recruiting
- NCT05527093 — Cartography of Social Cognition Network and Their Alterations in Patients With Epilepsy · NA · recruiting
- NCT06334952 — Efficacy of Personnalized Transcranial Direct Current Electrical Stimulation (tDCS) in Drug-resistant Epileptic · NA · recruiting
- NCT06708143 — Temporal Interference for Drug Resistant Epilepsy · NA · recruiting
- NCT06388707 — A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Dr · Phase 1, PHASE2 · recruiting
Other Beth Israel Deaconess Medical Center trials
Trials by the same sponsor.
- NCT07352657 — Remote Alert Pathway To Optimize CaRe of Cardiac Implantable Electrical Devices: The RAPTOR-CIED Study (Main Phase) · NA · not yet recruiting
- NCT07531602 — Effect of PEEP on Cardiac Function · NA · not yet recruiting
- NCT07534683 — Primed to Thrive: Investigating the Combined Impact of Mindfulness Education and Meditation Practice on Psychological an · NA · not yet recruiting
- NCT07277244 — Low-Intensity Mechanical Ventilation in the Operating Room: a Pilot Study · NA · enrolling by invitation
- NCT06896474 — SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07145489 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Beth Israel Deaconess Medical Center
- Last refreshed: 4 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07145489.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing